{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:12:17Z","timestamp":1794442337072,"version":"4.9.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160460"],"award-info":[{"award-number":["82160460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202919"],"award-info":[{"award-number":["82202919"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020205","name":"Health Commission of Jiangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB216068"],"award-info":[{"award-number":["20232BAB216068"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20232BAB206103"],"award-info":[{"award-number":["20232BAB206103"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20253BAC280124"],"award-info":[{"award-number":["20253BAC280124"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB216054"],"award-info":[{"award-number":["20212BAB216054"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20212BAB206041"],"award-info":[{"award-number":["20212BAB206041"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010857","name":"Jiangxi Provincial Department of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijbiomac.2026.152571","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:09:20Z","timestamp":1778911760000},"page":"152571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["USP33 contributes to EMT and Lenvatinib resistance by enhancing eEF1A1-mediated ILEI protein synthesis in hepatocellular carcinoma"],"prefix":"10.1016","volume":"367","author":[{"given":"Hongcheng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZhiHao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongcheng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.152571_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0010","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0020","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular therapies and precision medicine for hepatocellular carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0025","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2023.5997","article-title":"Diagnosis and Management of Cirrhosis and Its Complications: A Review","volume":"329","author":"Tapper","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0030","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3748\/wjg.v29.i8.1243","article-title":"Predictors of early and late hepatocellular carcinoma recurrence","volume":"29","author":"Nevola","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0035","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0040","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0045","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jceh.2019.07.012","article-title":"Systemic Therapy for Advanced Hepatocellular Carcinoma: An Update of a Rapidly Evolving Field","volume":"9","author":"Doycheva","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0055","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41419-023-05919-5","article-title":"Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity","volume":"14","author":"Yan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0060","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5582\/bst.2022.01535","article-title":"FOXA2 plays a critical role in hepatocellular carcinoma progression and lenvatinib-associated drug resistance","volume":"17","author":"Wang","year":"2023","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1153991","article-title":"Lenvatinib resistance mechanism and potential ways to conquer","volume":"14","author":"Bo","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1552741","article-title":"CRISPR\/Cas9 technology in tumor research and drug development application progress and future prospects","volume":"16","author":"Han","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0075","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1038\/s41467-019-12606-7","article-title":"Genome-wide CRISPR\/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC","volume":"10","author":"Wei","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0080","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/s41388-025-03581-z","article-title":"Targeting JMJD6\/PPARgamma\/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0085","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","article-title":"EGFR activation limits the response of liver cancer to lenvatinib","volume":"595","author":"Jin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0090","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12032-020-01350-4","article-title":"Activation of the HGF\/c-MET axis promotes lenvatinib resistance in hepatocellular carcinoma cells with high c-MET expression","volume":"37","author":"Fu","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0095","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neo.2017.12.003","article-title":"Anti-cancer Effects of HNHA and Lenvatinib by the Suppression of EMT-Mediated Drug Resistance in Cancer Stem Cells","volume":"20","author":"Lee","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ccr.2006.07.020","article-title":"ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells","volume":"10","author":"Waerner","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/iub.1585","article-title":"The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI)","volume":"69","author":"Sun","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0110","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/his.12435","article-title":"ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer","volume":"65","author":"Gao","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0115","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s13277-013-1188-y","article-title":"ILEI drives epithelial to mesenchymal transition and metastatic progression in the lung cancer cell line A549","volume":"35","author":"Song","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0120","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/onc.2008.418","article-title":"ILEI requires oncogenic Ras for the epithelial to mesenchymal transition of hepatocytes and liver carcinoma progression","volume":"28","author":"Lahsnig","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0125","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1038\/s41388-019-0703-z","article-title":"TGFbeta promotes breast cancer stem cell self-renewal through an ILEI\/LIFR signaling axis","volume":"38","author":"Woosley","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0130","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1111\/febs.14207","article-title":"Covalent dimerization of interleukin-like epithelial-to-mesenchymal transition (EMT) inducer (ILEI) facilitates EMT, invasion, and late aspects of metastasis","volume":"284","author":"Kral","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0135","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41418-019-0473-8","article-title":"Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer","volume":"27","author":"Guo","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0140","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1074\/jbc.M108269200","article-title":"Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0145","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1080\/15548627.2019.1656957","article-title":"USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy","volume":"16","author":"Niu","year":"2020","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0150","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cub.2009.07.040","article-title":"Deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells","volume":"19","author":"Buus","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0155","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.biocel.2011.05.016","article-title":"Type 2 deiodinase at the crossroads of thyroid hormone action","volume":"43","author":"Arrojo","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0160","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.29226","article-title":"USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration","volume":"136","author":"Huang","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0165","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s13238-014-0070-z","article-title":"USP33, a new player in lung cancer, mediates Slit-Robo signaling","volume":"5","author":"Wen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0170","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1159\/000488041","article-title":"USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma","volume":"45","author":"Jia","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0175","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.0801262106","article-title":"Deubiquitinating enzyme USP33\/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration","volume":"106","author":"Yuasa-Kawada","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0180","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12606","article-title":"Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT","volume":"52","author":"Xia","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118316","article-title":"USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma","volume":"261","author":"Gan","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0190","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.molcel.2011.02.003","article-title":"Identification of an mRNP complex regulating tumorigenesis at the translational elongation step","volume":"41","author":"Hussey","year":"2011","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0200","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1158\/0008-5472.CAN-15-3118","article-title":"The Ubiquitin-like Protein FAT10 Stabilizes eEF1A1 Expression to Promote Tumor Proliferation in a Complex Manner","volume":"76","author":"Liu","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188391","article-title":"Lenvatinib for hepatocellular carcinoma: From preclinical mechanisms to anti-cancer therapy","volume":"1874","author":"Zhao","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0210","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/638747","article-title":"Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models","volume":"2014","author":"Tohyama","year":"2014","journal-title":"J. Thyroid. Res."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110497","article-title":"The advancement of ubiquitination regulation in apoptosis, ferroptosis, autophagy, drug resistance and treatment of cancer","volume":"771","author":"Ling","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0220","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12943-024-02005-y","article-title":"Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options","volume":"23","author":"Gao","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0225","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2337\/db21-0857","article-title":"Hepatokine ERAP1 Disturbs Skeletal Muscle Insulin Sensitivity Via Inhibiting USP33-Mediated ADRB2 Deubiquitination","volume":"71","author":"Niu","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0230","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41580-018-0011-4","article-title":"Roadblocks and resolutions in eukaryotic translation","volume":"19","author":"Schuller","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.10.046","article-title":"Decoding Mammalian Ribosome-mRNA States by Translational GTPase Complexes","volume":"167","author":"Shao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0240","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cam4.4848","article-title":"eEF1A1 promotes colorectal cancer progression and predicts poor prognosis of patients","volume":"12","author":"Fan","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0245","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.3892\/or.2017.5543","article-title":"P21 activated kinase 4 binds translation elongation factor eEF1A1 to promote gastric cancer cell migration and invasion","volume":"37","author":"Li","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0250","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.bbrc.2017.10.116","article-title":"Overexpression of eEF1A1 regulates G1-phase progression to promote HCC proliferation through the STAT1-cyclin D1 pathway","volume":"494","author":"Huang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.devcel.2011.02.012","article-title":"Stopped in translation: EMT control meets eukaryotic elongation","volume":"20","author":"Zhang","year":"2011","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0265","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cell.2018.11.038","article-title":"METTL13 methylation of eEF1A increases translational output to promote tumorigenesis","volume":"176","author":"Liu","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0270","article-title":"Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis","volume":"10","author":"Li","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/gm83","article-title":"Networking of differentially expressed genes in human cancer cells resistant to methotrexate","volume":"1","author":"Selga","year":"2009","journal-title":"Genome Med."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0280","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12935-024-03330-4","article-title":"CDCA5-EEF1A1 interaction promotes progression of clear cell renal cell carcinoma by regulating mTOR signaling","volume":"24","author":"Wang","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ijbiomac.2026.152571_bb0285","first-page":"67","article-title":"Screening of lymphoma radiotherapy-resistant genes with CRISPR activation library","volume":"16","author":"Luo","year":"2023","journal-title":"Pharmgenomics Pers Med"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026024980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T13:54:17Z","timestamp":1783173257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026024980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":57,"alternative-id":["S0141813026024980"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152571","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP33 contributes to EMT and Lenvatinib resistance by enhancing eEF1A1-mediated ILEI protein synthesis in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.152571","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152571"}}